Contribution of the level of protein hydrolysis to the effects of small intestinal protein, on gut motility, gut hormone release and sensations of appetite.

Not Applicable

Withdrawn

• Conditions: Obesity; Diet and Nutrition - Obesity; Oral and Gastrointestinal - Normal oral and gastrointestinal development and function

• Registration Number: ACTRN12610000364077
• Lead Sponsor: Christine Feinle-Bisset

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-05-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Male
• Target Recruitment: 32

Inclusion Criteria

non-obese with a Body Mass Index (BMI) of 18-25 kg/m2 and obese with a BMI of 27-35 kg/m2

Weight stable (<5% fluctuation in body weight in previous 3 months)

Exclusion Criteria

Significant gastrointestinal symptoms, disease or surgery.
Use of prescribed or non-prescribed medications (including vitamins and herbal suppliments) which may affect energy metabolism, gastrointestinal function, body weight or appetite (eg domperidone and cisapride, anticholinergic drugs (eg atropine), metoclopramide, erythromycin, hyoscine, orlistat, green tea extracts, Astragalus, St Johns Wort etc)

Study & Design

• Study Type: Interventional
• Study Design: Not specified